We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16.5B
AUM Growth
+$861M
Cap. Flow
+$217M
Cap. Flow %
1.32%
Top 10 Hldgs %
30.08%
Holding
735
New
44
Increased
335
Reduced
212
Closed
49

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$60.1M
2
QCOM icon
Qualcomm
QCOM
+$53.4M
3
NU icon
Nu Holdings
NU
+$48.5M
4
AMZN icon
Amazon
AMZN
+$46.5M
5
BMA icon
Banco Macro
BMA
+$43.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40.8M
2
ADBE icon
Adobe
ADBE
+$36.1M
3
VIPS icon
Vipshop
VIPS
+$33.1M
4
SBUX icon
Starbucks
SBUX
+$31.4M
5
LOW icon
Lowe's Companies
LOW
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Healthcare 27.47%
3 Financials 9.69%
4 Consumer Discretionary 7.72%
5 Industrials 6.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCO icon
201
Moody's
MCO
$81.7B
$16.4M 0.1%
39,016
+1,311
+3% +$522K
MTZ icon
202
MasTec
MTZ
$26.7B
$16.4M 0.1%
153,010
-58,331
-28% -$5.89M
DFS
203
DELISTED
Discover Financial Services
DFS
$16.3M 0.1%
124,557
+96,920
+351% +$12.1M
BLD
204
DELISTED
TopBuild
BLD
$16.3M 0.1%
42,187
-4,860
-10% -$1.98M
ARVN icon
205
Arvinas
ARVN
$518M
$16.2M 0.1%
610,458
+147,904
+32% +$4.71M
EXEL icon
206
Exelixis
EXEL
$13.9B
$15.9M 0.1%
707,635
-47,842
-6% -$1.06M
BCYC
207
Bicycle Therapeutics
BCYC
$270M
$15.4M 0.09%
759,180
-130,078
-15% -$2.94M
EA icon
208
Electronic Arts
EA
$52.4B
$15M 0.09%
107,545
-30,299
-22% -$3.99M
GPK icon
209
Graphic Packaging
GPK
$3.26B
$14.8M 0.09%
563,964
-36,344
-6% -$1M
ORCL icon
210
Oracle
ORCL
$331B
$14.6M 0.09%
103,114
+7,708
+8% +$957K
VCYT icon
211
Veracyte
VCYT
$4.52B
$14.5M 0.09%
670,937
– –
TFC icon
212
Truist Financial
TFC
$63.2B
$14.4M 0.09%
371,817
+264,181
+245% +$9.98M
VZ icon
213
Verizon
VZ
$194B
$14.4M 0.09%
348,749
-305,849
-47% -$12.3M
TGT icon
214
Target
TGT
$62.1B
$14.2M 0.09%
95,932
+15,671
+20% +$2.47M
AGIO icon
215
Agios Pharmaceuticals
AGIO
$2.16B
$13.9M 0.08%
+322,882
New +$11.7M
OKTA icon
216
Okta
OKTA
$24.1B
$13.9M 0.08%
148,506
+72,828
+96% +$6.89M
IEX icon
217
IDEX
IEX
$16.5B
$13.8M 0.08%
68,526
+9,886
+17% +$2.16M
ANET icon
218
Arista Networks
ANET
$219B
$13.4M 0.08%
153,388
+50,640
+49% +$3.77M
DGX icon
219
Quest Diagnostics
DGX
$25.1B
$13.4M 0.08%
64,863
+5,375
+9% +$736K
MRSH
220
Marsh
MRSH
$86.3B
$13.3M 0.08%
63,355
+3,800
+6% +$781K
GIS icon
221
General Mills
GIS
$19.2B
$13.3M 0.08%
98,725
+158
+0.2% +$10.8K
LEA icon
222
Lear
LEA
$7.19B
$13.3M 0.08%
116,261
+34,582
+42% +$4.43M
KMB icon
223
Kimberly-Clark
KMB
$36.4B
$13.1M 0.08%
95,130
-1,691
-2% -$226K
DXCM icon
224
DexCom
DXCM
$27.6B
$13.1M 0.08%
115,749
-58,167
-33% -$7.35M
ROP icon
225
Roper Technologies
ROP
$36.3B
$13.1M 0.08%
23,263
+3,487
+18% +$1.88M
7 8
9
10 11

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2024 Portfolio in Review

As of Q2 2024, Candriam SCA held 735 positions worth $16.5B, up 5.5% from $15.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q2 2024 filing shows 44 new, 335 increased, 212 reduced and 49 closed positions. Its largest new stake was Banco Macro: 754,200 shares worth $43.2M. The largest sale was Apple, an estimated $40.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2024 buy was Banco Macro: 754,200 shares worth $43.2M.
  • Candriam SCA added most to Eli Lilly in Q2 2024, an estimated $60.1M increase.
  • Candriam SCA's biggest Q2 2024 reduction was Apple, cutting an estimated $40.8M.
  • Candriam SCA fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $16.5M.
  • Candriam SCA's ten largest holdings make up 30% of its $16.5B portfolio in Q2 2024.
  • Candriam SCA opened 44 new positions and closed 49 in Q2 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $16.5B.

Based on Candriam SCA's 13F filing for Q2 2024, filed 5 Aug 2024.